Assessment separates local findings from problems involving the infusion system or the patient’s overall response. Clinicians look for changes associated with infiltration, extravasation, phlebitis, hematoma, infection, and unexpected systemic reactions. This three-part review helps determine whether the infusion should be stopped or adjusted, whether condition-specific care is needed, and whether escalation is appropriate.
Prompt recognition and intervention can limit tissue injury before a local problem progresses. Timely action also helps prevent serious infection or circulatory complications and reduces interruption of needed therapy. Because intravenous treatment may deliver fluids, medications, blood products, or nutrition, rapid attention supports both patient safety and the intended therapeutic outcome.
Monitoring should include the catheter site, the infusion system, and the patient. Relevant concerns include infiltration, extravasation, phlebitis, hematoma, infection, and unexpected systemic reactions. Reviewing these areas together is important because an abnormality may appear locally at the access site, arise from the delivery system, or reflect a broader patient response.
The initial response depends on the observed complication, but the infusion may need to be stopped or adjusted while the finding is assessed. Clinicians then provide care specific to the condition and determine whether escalation is required. This sequence connects recognition with intervention rather than allowing an abnormal finding to remain undocumented or untreated.
Standardized documentation creates a consistent record of the assessment, response, and subsequent care. It improves communication among clinicians, supports decisions about escalation, and helps teams follow the course of a complication. At the organizational level, these records contribute to quality improvement by revealing patterns in IV-related adverse events and management.
It is relevant whenever intravenous access supports delivery of fluids, medications, blood products, or nutrition, including practice in hospitals and other healthcare settings. The approach addresses both prevention and response, helping clinicians protect the access site, recognize unexpected patient reactions, and maintain safer delivery of therapies that depend on reliable intravenous access.